Company profile: ShangPharma Innovation
1.1 - Company Overview
Company description
- Provider of global innovation incubation and investment focused on biomedical R&D technologies and therapeutics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ShangPharma Innovation
Jean Brown Research
HQ: United States
Website
- Description: Provider of clinical research site management services, conducting post-operative pain studies for pharmaceutical companies. With 30+ years of experience in pain management protocols, vaccine testing, and phase I-IV studies, JBR operates two facilities near Salt Lake City, Utah and trains staff in patient interaction to deliver accurate, detailed study results using proprietary training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jean Brown Research company profile →
Trillium Health Care Products
HQ: Canada
Website
- Description: Provider of contract manufacturing, formulation, packaging, and project management for OTC and natural health products. Capabilities span solid dose (tablets, capsules, granules, powders), liquid dose (solutions, suspensions, lotions, syrups), and semi-solid dose (creams, ointments, wax-based suppositories), plus tube/jar/suppository filling, specialized labeling and custom display packaging, and concept-to-commercialization support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trillium Health Care Products company profile →
Optimer Pharmaceuticals
HQ: United States
Website
- Description: Provider of anti-infective biopharmaceutical products focused on discovering, developing and commercializing treatments for gastrointestinal infections, including late-stage candidates fidaxomicin and Pruvel (prulifloxacin).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optimer Pharmaceuticals company profile →
ProSciento
HQ: United States
Website
- Description: Provider of clinical research and development services, leveraging broad scientific expertise, direct patient access, advanced methodologies, and integrated operations to advance science and achieve quality results through client and partner connections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProSciento company profile →
KCAS Bio
HQ: United States
Website
- Description: Provider of bioanalytical research services to pharmaceutical, biotech, animal health, and medical device companies, employing carefully validated processes to deliver timely information and insight, giving clients the confidence needed to launch innovative products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full KCAS Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ShangPharma Innovation
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ShangPharma Innovation
2.2 - Growth funds investing in similar companies to ShangPharma Innovation
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ShangPharma Innovation
4.2 - Public trading comparable groups for ShangPharma Innovation
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →